Meltzer Leslie

Meltzer Leslie is listed in filings as Chief Research and Development at Apellis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including 8 public disclosures. Recent filings connect the profile to Apellis Pharmaceuticals, Inc. (APLS). The current snapshot covers public activity from Sep 2, 2025 to May 14, 2026. Reported amounts are shown as $2.6M to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.